Thomas Louis

Professor Emeritus

1971 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1971 2020

Filter
Letter
2005

NINDS Reanalysis Committee's reanalysis of the NINDS trial [4] (multiple letters)

Mann, J., Ingall, T. J., O'Fallon, W. M., Asplund, K., Goldfrank, L. R., Hertzberg, V. S., Louis, T. & Christianson, T. J. H., Feb 2005, In : Stroke. 36, 2, p. 230-231 2 p.

Research output: Contribution to journalLetter

National Institute of Neurological Disorders and Stroke
Statistical Data Interpretation
Fibrinolytic Agents
Tissue Plasminogen Activator
Randomized Controlled Trials

NINDS stroke trial data reanalysis leaves issues unresolved [4] (multiple letters)

Smith, B., Ingall, T. J., O'Fallon, W. M., Christianson, T. J. H., Asplund, K., Goldfrank, L. R., Hertzberg, V. S. & Louis, T., Mar 2005, In : Stroke. 36, 3, p. 529-530 2 p.

Research output: Contribution to journalLetter

National Institute of Neurological Disorders and Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
Recombinant Proteins
Stroke
2003

Cardiovascular Disease and HIV Infection [3] (multiple letters)

Klein, D., Hurley, L. B., Sidney, S., Bozzette, S. A. & Louis, T., Nov 6 2003, In : New England Journal of Medicine. 349, 19, p. 1869-1870 2 p.

Research output: Contribution to journalLetter

Cardiovascular Infections
HIV Protease Inhibitors
Anti-HIV Agents
Highly Active Antiretroviral Therapy
HIV Infections
1995

The authors reply: Simpler common-sense methods may be preferable to “empirical bayes”

Devine, O. J., Louis, T. & Halloran, M. E., 1995, In : Epidemiology. 6, 3, p. 338 1 p.

Research output: Contribution to journalLetter

1989

REPLY

Louis, T. & Manu, P., 1989, In : Journal of Clinical Pharmacy and Therapeutics. 14, 6, p. 481-482 2 p.

Research output: Contribution to journalLetter

1982

Radiation effects [5]

Louis, T., 1982, In : Science. 215, 4532, p. 458 1 p.

Research output: Contribution to journalLetter